Cargando…

N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer

BACKGROUND: Bladder cancer (BC) is a commonly occurring malignant tumor of the urinary system, demonstrating high global morbidity and mortality rates. BC currently lacks widely accepted biomarkers and its predictive, preventive, and personalized medicine (PPPM) is still unsatisfactory. N6-methylade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Miaolong, Zhan, Hailun, Liu, Bolong, Li, Dongyang, Li, Wenbiao, Chen, Xuelian, Zhou, Xiangfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648947/ https://www.ncbi.nlm.nih.gov/pubmed/34950253 http://dx.doi.org/10.1007/s13167-021-00259-w

Ejemplares similares

Houttuynia cordata Extract Ameliorates Bladder Damage and Improves Bladder Symptoms via Anti-Inflammatory Effect in Rats with Interstitial Cystitis
por: Li, Wenbiao, et al.
Publicado: (2020)

Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
por: Yu, Xinshuang, et al.
Publicado: (2021)

Spinal astrocytic activation contributes to mechanical allodynia in a rat model of cyclophosphamide-induced cystitis
por: Liu, Bolong, et al.
Publicado: (2016)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
por: Sun, Junjun, et al.
Publicado: (2021)

N(6)-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors
por: Zhan, Lei, et al.
Publicado: (2021)

N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma
por: Yang, Kun, et al.
Publicado: (2022)

Inflammatory pseudotumor of Castleman disease and IgG4-related disease masquerading as kidney malignancy
por: Liu, Bolong, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis
por: Ding, Honglu, et al.
Publicado: (2020)

N ( 6 )-Methyladenosine-Related Long Non-Coding RNAs Are Identified as a Potential Prognostic Biomarker for Lung Squamous Cell Carcinoma and Validated by Real-Time PCR
por: Zhang, Wei, et al.
Publicado: (2022)

An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer
por: Ma, Tianming, et al.
Publicado: (2021)

Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer
por: Xue, M. Q., et al.
Publicado: (2022)

N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma
por: Ma, Tianming, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer
por: Huang, Ziye, et al.
Publicado: (2022)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer
por: Luo, Lin, et al.
Publicado: (2022)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

Umbilical Cord Mesenchymal Stem Cells Overexpressing Heme Oxygenase-1 Promotes Symptoms Recovery in Cystitis Rats by Alleviating Neuroinflammation
por: Gao, Qiongqiong, et al.
Publicado: (2023)

Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder Cancer
por: Lin, Gaoteng, et al.
Publicado: (2021)

Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients
por: Huang, Xin, et al.
Publicado: (2022)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Immunotherapeutic strategies for bladder cancer
por: Chevalier, Mathieu F, et al.
Publicado: (2014)

N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer
por: Shi, Rui, et al.
Publicado: (2021)

GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer
por: Wang, Yunfei, et al.
Publicado: (2023)

The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker
por: Zhang, Yong, et al.
Publicado: (2022)

Interplay Between N(6)-Methyladenosine (m(6)A) and Non-coding RNAs in Cell Development and Cancer
por: Fazi, Francesco, et al.
Publicado: (2019)

The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer
por: Lu, Senxu, et al.
Publicado: (2021)

N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma
por: Wu, Zhongguang, et al.
Publicado: (2022)

Notch1 Signaling Contributes to Mechanical Allodynia Associated with Cyclophosphamide-Induced Cystitis by Promoting Microglia Activation and Neuroinflammation
por: Chen, Jialiang, et al.
Publicado: (2021)

Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract
por: Cai, Lei, et al.
Publicado: (2023)

Identification and characterization of N6‐methyladenosine modification of circRNAs in glioblastoma
por: Zhang, Yuhao, et al.
Publicado: (2021)

Extensive translation of circular RNAs driven by N(6)-methyladenosine
por: Yang, Yun, et al.
Publicado: (2017)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

MicroRNAs as novel immunotherapeutics
por: Heimberger, Amy B, et al.
Publicado: (2013)

N6-Methyladenosine Related Long Non-Coding RNAs and Immune Cell Infiltration in the Tumor Microenvironment of Gastric Cancer
por: Yu, Zhong lin, et al.
Publicado: (2021)

Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma
por: Yu, Zhong Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i1ec7pnqpb54rpvd4g5jr3n4pf